tiprankstipranks
Trending News
More News >
Vivoryon Therapeutics AG (NL:VVY)
:VVY
Netherlands Market

Vivoryon Therapeutics AG (VVY) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Buy
6Bullish
3Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Vivoryon Therapeutics AG’s (VVY) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Vivoryon Therapeutics AG is a Buy.
Vivoryon Therapeutics AG’s (VVY) 20-Day exponential moving average is 1.41, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) 50-Day exponential moving average is 1.45, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.

Vivoryon Therapeutics AG (VVY) Pivot Points

Mar 13, 2026, 05:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.29
1.32
1.34
1.38
1.39
1.43
1.44
Fibonacci
1.32
1.34
1.36
1.38
1.40
1.41
1.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivoryon Therapeutics AG (VVY) Moving Averages

Mar 13, 2026, 05:53 PM
Period
Simple
Exponential
MA5
1.38Buy
1.38Buy
MA10
1.40Sell
1.39Sell
MA20
1.40Sell
1.41Sell
MA50
1.47Sell
1.45Sell
MA100
1.53Sell
1.50Sell
MA200
1.54Sell
1.56Sell
Vivoryon Therapeutics AG’s (VVY) 10-Day exponential moving average is 1.39, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) 100-Day exponential moving average is 1.50, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 50-day simple moving average is 1.47, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 100-day simple moving average is 1.53, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 200-day simple moving average is 1.54, creating a Sell signal.

Vivoryon Therapeutics AG (VVY) Technical Indicators

Mar 13, 2026, 05:53 PM
Name
Value
Implied Action
RSI (14)
44.33
Neutral
STOCH (9,6)
9.47
Buy
STOCHRSI (14)
14.06
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
17.31
Buy
Williams %R
-79.45
Buy
CCI (14)
-64.15
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
33.98
Neutral
ROC
2.22
Buy
Vivoryon Therapeutics AG’s (VVY) Relative Strength Index (RSI) is 44.33, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Trend Strength Indicator (ADX) is 17.31, creating a Buy signal.
Vivoryon Therapeutics AG’s (VVY) Commodity Channel Index (CCI) is -64.15, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Price Rate of Change (ROC) is 2.22, creating a Buy signal.

FAQ

Is VVY a Buy, Hold, or Sell?
Based on VVY’s technical indicators, VVY is a Sell.
    What is VVY’s RSI (14)?
    VVY’s RSI (14) is 44.33, which suggests VVY is a Neutral.
      What is VVY’s MACD?
      VVY’s MACD is -0.02, which suggests VVY is a Buy.
        What is VVY’s 5-day moving average?
        VVY’s 5-day moving average is 1.38, which suggests VVY is a Buy.
          What is VVY’s 20-day moving average?
          VVY 20-day moving average is 1.40, which suggests VVY is a Sell.
            What is VVY’s 50-day moving average?
            VVY’s 50-day moving average is 1.47, which suggests VVY is a Sell.
              What is VVY’s 200-day moving average?
              VVY’s 200-day moving average is 1.54, which suggests VVY is a Sell.
                What is VVY’s Williams % R (14)?
                VVY’s Williams % R (14) is -79.45, which suggests VVY is a Buy.
                  What is VVY’s CCI (14)?
                  VVY’s CCI (14) is -64.15, which suggests VVY is a Neutral.
                    What is the share price of Vivoryon Therapeutics AG?